Lacerta Therapeutics
Arun Srivastava is an advisor at Lacerta Therapeutics. Arun was previously an assistant professor at the University of Arkansas for Medical Sciences from January 1982 to December 1985. Arun was also a research associate at the University of Florida College of Medicine from January 1980 to December 1982. Arun's most recent position was as a postdoctoral fellow at the Memorial Sloan-Kettering Cancer Center from January 1978 to December 1980.
Arun Srivastava earned a Bachelor of Science in Biology from Ewing Christian College, University of Allahabad. Arun then went on to earn a Master of Science in Biochemistry from the University of Allahabad. Finally, they earned a Doctor of Philosophy in Microbiology from the Indian Institute of Science.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous system and lysosomal storage diseases. With unmatched scientific expertise and depth in the development, production, and application of AAV vectors, LacertaTherapeutics is advancing its clinical programs using its proprietary capsid variants and scalable vector manufacturing platform. The experience and accomplishments of the Lacerta Therapeutics founders are unsurpassed in AAV gene therapy. In addition to world-class basic AAV vector development and gene therapy clinical trial expertise, our team brings to bear individuals with novel insight into developing novel, targeted neurological and lysosomal storage disease treatments.